MLIV (mucolipidosis type IV) is a neurodegenerative lysosomal storage disorder caused by mutations in MCOLN1, a gene that encodes TRPML1 (mucolipin-1), a member of the TRPML (transient receptor potential mucolipin) cation channels. Two additional homologues are TRPML2 and TRPML3 comprising the TRPML subgroup in the TRP superfamily. The three proteins play apparently key roles along the endocytosis process, and thus their cellular localization varies among the different group members. Thus TRPML1 is localized exclusively to late endosomes and lysosomes, TRPML2 is primarily located in the recycling clathrinindependent GPI (glycosylphosphatidylinositol)-anchored proteins and early endosomes, and TRPML3 is primarily located in early endosomes. Apparently, all three proteins' main physiological function underlies Ca 2+ channelling, regulating the endocytosis process. Recent findings also indicate that the three TRPML proteins form heteromeric complexes at least in some of their cellular content. The physiological role of these complexes in lysosomal function remains to be elucidated, as well as their effect on the pathophysiology of MLIV. Another open question is whether any one of the TRPMLs bears additional function in channel activity
Introduction
MLIV (mucolipidosis type IV, MIM#252650) is an LSD (lysosomal storage disorder) presenting unique features in the LSD group either in the clinical picture or the nature of the basic metabolic defect underlying this syndrome.
MLIV, first described in 1974 [1] , is a neurodegenerative disorder characterized by severe psychomotor retardation, ophthalmological abnormalities, iron deficiency and achlorohydria [2] [3] [4] . Although the disease manifests already in young infancy, the syndrome, unlike most other early-agemanifesting LSDs, has extremely slow clinical progression and, if plasma iron levels are balanced appropriately, patients live for over four or five decades [3, 4] ; life expectancy is still not clear. Mildly affected patients, primarily regarding psychomotor retardation, have also been described [5] [6] [7] .
MCOLN1 was identified to be the gene mutated in MLIV [8] [9] [10] . The gene is located on human chromosome locus 19p13.2-13.3 [11] . MLIV is found in relatively high frequency among Ashkenazi Jews, thus a large proportion of patients that have been diagnosed, at least in the past, belonged to this ethnic group [3, 12, 13] . Two founder mutations in the MCOLN1 gene constitute over 95 % of the mutant alleles in this ethnic group with a carrier frequency of 1:100 [14, 15] . Population screening programmes aiming for the detection of heterozygotes for prevalent recessive disorders before the birth of the first affected offspring have been offered to the Israeli population in recent years [16] . MLIV has been included in these programmes, resulting in a significant reduction in the birth of newly diagnosed patients in the last 5 years [16] .
MLIV was defined as a mucolipidosis due to the simultaneous lysosomal accumulation of membranous lipid substances together with granulated water-soluble materials in cells of every tissue and organs of these patients [17] [18] [19] [20] [21] . Chemical analyses indicated the storage of a heterogeneous group of lipids, including gangliosides, phospholipidosis and acid mucopolysaccharides, together with various glycoproteins [3] . Furthermore, the stored substances in MLIV-cultured fibroblasts are autofluorescent, which is used as a diagnostic aid [22] .
The storage in MLIV apparently does not stem from a defective or deficient lysosomal hydrolase activity or a related protein, which is the cause in most other LSDs, but rather the abnormal storage stems from a defect in the endocytic process in the cell, probably in the biogenesis of lysosomes [23] [24] [25] [26] . It was thus suggested that most of the storage occurs in prelysosomal vesicles in the process of cargo transfer from late endosomes to lysosomes [24] . It should be noted that another LSD, namely Niemann-Pick type C (NPC, MIM#257220, #607625), was also suggested to be caused by a defect in the endocyosis process [27] [28] [29] [30] . Thus MLIV and NPC should be classified as a distinct subgroup among the LSDs of endocytic defective transport of macromolecules. Furthermore, both diseases were also implicated in defective autophagy [27, [31] [32] [33] , which might be an important factor in the pathophysiologal outcome in these syndromes.
Mucolipins
The identification of MCOLN1 led to the identification of two additional genes, both located on human chromosome 1, namely MCOLN2 and MCOLN3 [8] . The three genes encode the mucolipins (designated as mucolin 1, mucolipin 2 and mucolipin 3 respectively), comprising the mucolipin protein family. The structure of these proteins indicate them to be membrane proteins with six transmembrane domains and structural similarities with the TRP (transient receptor potential) superfamily of cation channels, mostly Ca 2+ channels [34, 35] . Thus the mucolipins are also classified and known as TRPMLs (TRP mucolipins) (1, 2 and 3 respectively), comprising a distinct subgroup in this superfamily. In parallel with the identification of the human MCOLN genes, homologous genes have also been identified in mice [36] , nematode worms (Caenorhabditis elegans) [37] [38] [39] [40] , Drosophila [41] and Xenopus (G. Bach, A. Frumkin and A. Feinsold, unpublished work). MLIV-causing mutations were therefore introduced to these organisms, resulting in phenotypes reminiscent of MLIV such as lysosomal storage defects, various cellular abnormalities as well as phenotypic manifestations of neurological abnormalities [41] . Indeed, the production of a mouse Mcoln1-knockout is an important tool for the investigation of the pathophysiology of MLIV as well as the development of treatment protocols for this disorder [36] .
TRPML functions
The basic metabolic function of the TRPMLs is still not fully resolved, and conflicting data regarding this issue have been reported occasionally. Nevertheless, there is a consensus that TRPML1 is a non-selective rectifying cation channel that is permeable to both uni-and bi-valent cations [42] [43] [44] [45] . The other two TRPMLs are cation channels as well. It is also clear that TRPML1 is located exclusively in late endosomes/lysosomal vesicles [46] [47] [48] [49] [50] [51] . It is not yet fully resolved whether TRPML1 functions as an outwardly or inwardly rectifying channel permeable to Ca 2+ , but the overall emerging data regarding its physiological function as an important factor in the late stages of the endocytotic process indicate that the inwardly rectifying channel is indeed the direction of current, from the lysosomal lumen out to the cytoplasm. Indeed, previous data indicated that Ca 2+ efflux is essential in the biogenesis of lysosomes during the transport from late endosomes to multivesicular bodies and mature lysosomes [51] . This points out that the main function of TRPML1 is apparently a Ca 2+ channel playing a key role in the biogenesis of lysosomes [13, 52] . Thus mutations leading to the malfunction of TRPML1 will lead to abnormal trafficking at these stages of endocytosis, resulting in storage of membrane components in prelysosomal vacuoles, as apparently occurs in MLIV. Whether TRPML1 is constituvely active or regulated by other agents is still not yet fully resolved. An earlier report indicated that NAADP acts as an activator [53] . Furthermore, it was also shown that TRPML1 is regulated by low pH [54] . It should be noted that the primary difficulty in the evaluation of TRPML1 function is the lysosomal localization of this protein, and this intracellular localization poses objective difficulties in representative measurements of its electrophysiological properties in situ. Only one study has so far managed to obtain direct lysosomal current measurements for TRPML1 [55] . This study also indicated that TRPML1 also functions as an Fe 2+ channel, in addition to Ca 2+ and other bivalent cations [55] . The results suggest that Fe 2+ is also not sufficiently exported from the lysosomal milieu in MLIV, leading to cellular deficiency of this cation [55] , explaining the iron deficiency in MLIV patients which is a characteristic manifestation of these patients [2] [3] [4] . In contrast with the data outlined above, another study indicated that TRPML1 functions as an H + channel in mature lysosomes which is inhibited by Ca 2+ [49] . This study suggested that TRPML1 functions as a pH regulator to prevent lysosomal overacidification [49] . These findings have not yet been confirmed. The assumption that TRPML1 is indeed a Ca 2+ (and Fe 2+ ) channel is certainly more suitable to explain its key function as a regulator in the biogenesis of lysosomes and the storage in multivesicle body-like vacuoles when TRPML1 does not function properly in MLIV or in the animal models, as mentioned above.
Regarding these issues, a number of questions still remain open. Does TRPML1 function only as a cation channel? TRPML1 contains also a serine lipase domain between transmembrane domains 1 and 2 [8] ; is this site enzymatically active as a lipase or as a lipid transporter? At present, there are no clear data that address this issue. Another key question relates to the protein-protein interactions resulting in the formation of homomers or heteromers. It should be noted that most TRP proteins are known to function in vivo in multimeric (homomers or oligomers) forms [34, 35] . TRPML1 might function differently as a monomeric protein as well as in multimeric complex(es); this is addressed further in the present article.
TRPML2 and TRPML3 exhibit considerable homology, particularly in the channel pore domain, with TRPML1 [8] , together making up the mucolipin protein family. Their function is also apparently similar, as cation channels are interrelated. Unlike MLIV, there is no human disease known at present related to the deficiency of either one of the other members of the mucolipin family. However, TRPML3 mutations were described in mice, including the varitintwaddler (Va) mouse mutant in which a gain-of-function mutation in TRPML3 leads to pigmentation abnormalities, hearing loss and embryonic lethality [56] . Both TRPML2 and TRPML3 were found to be localized partially in the plasma membrane and primarily in vesicles along the endocytic pathway [57] [58] [59] [60] . TRPML2 was demonstrated to be part of the long tubular vesicles, CD63 and lamp1 (lysosome-associated membrane protein 1)-positive, with GPI (glycosylphosphatidylinositol)-anchored proteins [57] . These vacuoles are attributed to recycling early endosomes of the Arf5 (ADP-ribosylation factor 5) pathway which is clathrin-independent. The protein is expressed primarily in B-lymphocytes. TRPML3 is expressed primarily in inner ear compartments and melanocytes [59] [60] [61] [62] [63] [64] and is intracellularly localized, in addition to the plasma membrane, in early endosomal vesicles [52] .
TRPML2 was shown to be an inwardly rectifying cation channel open to Ca 2+ , but not regulated by this cation [65] . TRPML3 also functions as a Ca 2+ channel and, indeed, overexpression of this protein as well as dominant-negative mutations result in a constant open channel and intracellular Ca 2+ load causing toxicity [58, [60] [61] [62] [63] [64] . It is still not fully assessed whether TRPML3 is regulated, although it has been reported that low Na + activates this channel [62] . The cellular distribution of the three TRPML proteins in different vesicles along the endocytic pathway implies their key role function in this process, apparently as Ca 2+ or other cation channels regulating the transport of these vesicles [52] . TRPML3 also functions in autophagy [66, 67] .
We shall bear in mind that most of the studies regarding TRPML function were performed in overexpressed heterologous systems frequently with introduced mutations with the aim to translocate them to the plasma membrane. This is of particular importance for TRPML1, which is localized in intracellular late endolysosomal vesicles only [46] [47] [48] [49] [50] [51] and thus electrophysiological measurements are required. But does this indeed represent the overall picture in vivo? Furthermore, TRPs in general are known to function mostly as homomers or heteromers [34, 35] . This, of course, might apply to the TRPMLs as well. Thus overexpression of one member might mask heteromeric complexes. Indeed, a few studies have indicated that the three TRPMLs form complexes, including all three members, at least in part of their cellular content [50, 68, 69] . This implies that lysosomes may indeed contain TRPML2 and TRPML3 in addition to TRPML1 due to this interaction and this was indeed reported [50, 68] . It has also been shown that TRPML1 forms a complex with the penta-EF-hand protein ALG2 [70] . It still remains to be studied what is the relevance of these complexes to the electrophysiological function of lysosomal TRPML as cation channels, in addition to the monomeric form of TRPML1 and the relevance for better understanding of the basic defect in MLIV. It is known that some TRP proteins show different function as oligomers compared with monomers.
The study of TRPMLs has opened a door to new insights into an understanding of the endocytosis process, but various issues await further elucidation.
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